These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1909414)

  • 41. Inactivation of the Creutzfeldt-Jakob disease agent.
    Tamai Y; Taguchi F; Miura S
    Ann Neurol; 1988 Sep; 24(3):466-7. PubMed ID: 3067657
    [No Abstract]   [Full Text] [Related]  

  • 42. Growth factor production by Creutzfeldt-Jakob disease cell lines.
    Oleszak EL; Murdoch G; Manuelidis L; Manuelidis EE
    J Virol; 1988 Sep; 62(9):3103-8. PubMed ID: 3043023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease.
    Manuelidis L; Sklaviadis T; Akowitz A; Fritch W
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5124-8. PubMed ID: 7761460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Creutzfeldt-Jakob disease agent (Echigo-1 strain) recovered from brain tissue showing the 'panencephalopathic type' disease.
    Mori S; Hamada C; Kumanishi T; Fukuhara N; Ichihashi Y; Ikuta F; Miyatake T; Tsubaki T
    Neurology; 1989 Oct; 39(10):1337-42. PubMed ID: 2677833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safe method for isolation of prion protein and diagnosis of Creutzfeldt-Jakob disease.
    Bastian FO; McDermott ME; Perry AS; Carver LA; Dash S; Garry RF
    J Virol Methods; 2005 Dec; 130(1-2):133-9. PubMed ID: 16102852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease.
    Owen F; Poulter M; Lofthouse R; Collinge J; Crow TJ; Risby D; Baker HF; Ridley RM; Hsiao K; Prusiner SB
    Lancet; 1989 Jan; 1(8628):51-2. PubMed ID: 2563037
    [No Abstract]   [Full Text] [Related]  

  • 47. Creutzfeldt-Jakob disease.
    Weinstein M
    Neurol Res; 1992 Sep; 14(4):355-6. PubMed ID: 1360634
    [No Abstract]   [Full Text] [Related]  

  • 48. Reevaluation of the ultrastructural pathology of experimental Creutzfeldt-Jakob disease. Serial studies of the Fujisaki strain of Creutzfeldt-Jakob disease virus in mice.
    Liberski PP; Yanagihara R; Asher DM; Gibbs CJ; Gajdusek DC
    Brain; 1990 Feb; 113 ( Pt 1)():121-37. PubMed ID: 2405952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture.
    Lawson VA; Vella LJ; Stewart JD; Sharples RA; Klemm H; Machalek DM; Masters CL; Cappai R; Collins SJ; Hill AF
    Int J Biochem Cell Biol; 2008; 40(12):2793-801. PubMed ID: 18590830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absence of Evidence for a Causal Link between Bovine Spongiform Encephalopathy Strain Variant L-BSE and Known Forms of Sporadic Creutzfeldt-Jakob Disease in Human PrP Transgenic Mice.
    Jaumain E; Quadrio I; Herzog L; Reine F; Rezaei H; Andréoletti O; Laude H; Perret-Liaudet A; Haïk S; Béringue V
    J Virol; 2016 Dec; 90(23):10867-10874. PubMed ID: 27681129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The infectivity is dissociated from PrP accumulation in salivary gland of Creutzfeldt-Jakob disease agent-inoculated mice.
    Miyamoto T; Sakaguchi S; Katamine S; Moriuchi R
    Ann N Y Acad Sci; 1994 Jun; 724():310-3. PubMed ID: 7913302
    [No Abstract]   [Full Text] [Related]  

  • 52. Cerebral amyloid in mice with Creutzfeldt-Jakob disease is influenced by the strain of the infectious agent.
    Kitamoto T; Yi R; Mohri S; Tateishi J
    Brain Res; 1990 Jan; 508(1):165-7. PubMed ID: 2186845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
    Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
    Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease.
    Deslys JP; Marcé D; Dormont D
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():23-7. PubMed ID: 8113733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A traceback phenomenon can reveal the origin of prion infection.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Creutzfeldt-Jakob disease. Failure to detect spiroplasmas by cultivation and serological tests.
    Leach RH; Matthews WB; Will R
    J Neurol Sci; 1983 Jun; 59(3):349-53. PubMed ID: 6348215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Creutzfeldt-Jakob disease.
    Manuelidis EE
    J Neuropathol Exp Neurol; 1985 Jan; 44(1):1-17. PubMed ID: 3880808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for an unconventional virus in mouse-adapted Creutzfeldt-Jakob disease.
    Kingsbury DT; Smeltzer DA; Amyx HL; Gibbs CJ; Gajdusek DC
    Infect Immun; 1982 Sep; 37(3):1050-3. PubMed ID: 6752018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attenuated Creutzfeldt-Jakob Disease agents can hide more virulent infections.
    Manuelidis L; Yun Lu Z
    Neurosci Lett; 2000 Nov; 293(3):163-6. PubMed ID: 11036186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inactivation of prions by acidic sodium dodecyl sulfate.
    Peretz D; Supattapone S; Giles K; Vergara J; Freyman Y; Lessard P; Safar JG; Glidden DV; McCulloch C; Nguyen HO; Scott M; Dearmond SJ; Prusiner SB
    J Virol; 2006 Jan; 80(1):322-31. PubMed ID: 16352557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.